Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Norton

Showing results (301-310 of 305) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 305 results.
RMD Open|February 11, 2026
Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysisSumera Qureshi, Maryam Adas, Phoebe J Cope, et al.
The British Journal of Dermatology|February 1, 2022
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional surveyKatie Bechman, Emma S Cook, Nick Dand, et al.
The British Journal of Dermatology|February 10, 2023
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional surveySophia Quirke-McFarlane, John Weinman, Emma S Cook, et al.
Wellcome Open Research|May 31, 2022
A comprehensive high cost drugs dataset from the NHS in England - An OpenSAFELY-TPP Short Data ReportAnna Rowan, Chris Bates, William Hulme, et al.
The Lancet. Rheumatology|June 14, 2022
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platformBrian MacKenna, Nicholas A Kennedy, Amir Mehrkar, et al.
Pageof 31

Showing results (301-310 of 305) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 305 results.
RMD Open|February 11, 2026
Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysisSumera Qureshi, Maryam Adas, Phoebe J Cope, et al.
The British Journal of Dermatology|February 1, 2022
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional surveyKatie Bechman, Emma S Cook, Nick Dand, et al.
The British Journal of Dermatology|February 10, 2023
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional surveySophia Quirke-McFarlane, John Weinman, Emma S Cook, et al.
Wellcome Open Research|May 31, 2022
A comprehensive high cost drugs dataset from the NHS in England - An OpenSAFELY-TPP Short Data ReportAnna Rowan, Chris Bates, William Hulme, et al.
The Lancet. Rheumatology|June 14, 2022
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platformBrian MacKenna, Nicholas A Kennedy, Amir Mehrkar, et al.
Pageof 31